Close Menu
    Facebook X (Twitter) Instagram
    Mediarun Search
    Facebook X (Twitter) Instagram
    Mediarun Search
    Home»science»needle end? AstraZeneca is testing a nasal Covid-19 vaccine
    science

    needle end? AstraZeneca is testing a nasal Covid-19 vaccine

    Camelia KirkBy Camelia KirkAugust 2, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    needle end?  AstraZeneca is testing a nasal Covid-19 vaccine
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Good news for those who are afraid of injections (almost everyone, right?): British laboratory AstraZeneca has successfully tested an aerosol version of the Covid-19 vaccine. The survey is conducted in the United Kingdom and the United States.

    But calm down! There is still a long way to escape from the sting. At the moment, tests have only been done on animals, such as hamsters and monkeys. But the researchers did find that applying the nasal vaccine helped reduce the viral load in the control group, causing the virus to spread less.

    publicity celebrity

    The effects of Covid-19 on hamsters are similar to what happens to humans. Credit: Wirestock/Freepik

    Recent studies have shown that transmission of the virus is possible even from people who have already been vaccinated, which reinforces the importance of wearing masks and maintaining social distance. Nasal application is an additional option to prevent further spread of the virus.

    In another recent research, scientists at the University of Alabama, USA, concluded that intranasal application of vaccines makes more sense to fight the disease, because the path of COVID-19 infection runs through the nose, throat and lungs. But the use of an immune spray should ensure protection only for a shorter time than when applied intramuscularly.

    Researchers suggest that the best option to protect yourself from the virus is to combine application to the arm and application to the nose, to ensure a greater range of protection.

    Earlier this year, Jorge Kalil Filho, director of the Immunology Laboratory at Instituto do Coração at Hospital das Clínicas, Faculty of Medicine, revealed that he had conducted advanced studies to produce a 100% national version of the immunizing agent against Covid-19. But no date has been set for the start of testing yet.

    See also  Procon is suing maladaptive re-adaptation health plans

    Source: Medical ExpressAnd USP . magazine

    You have seen our new videos on Youtube? Subscribe to our channel!

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Camelia Kirk

    "Friendly zombie guru. Avid pop culture scholar. Freelance travel geek. Wannabe troublemaker. Coffee specialist."

    Related Posts

    Can members transplant change a person's personality?

    August 18, 2025

    The new European Union system for UK travelers: It is not necessary

    August 18, 2025

    Teenagers who have the worst mental health spend more time on social networks

    August 16, 2025
    Leave A Reply Cancel Reply

    Navigate
    • Home
    • Top News
    • World
    • Economy
    • science
    • Technology
    • sport
    • entertainment
    • Contact Form
    Pages
    • About Us
    • Privacy Policy
    • DMCA
    • Editorial Policy
    • Contact Form
    MAIN MENU
    • Home
    • Top News
    • World
    • Economy
    • science
    • Technology
    • sport
    • entertainment
    • Contact Form
    Facebook X (Twitter) Instagram Pinterest
    © 2025 ThemeSphere. Designed by ThemeSphere.

    Type above and press Enter to search. Press Esc to cancel.